These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 10532952)
1. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. Yang Q; Sanbe A; Osinska H; Hewett TE; Klevitsky R; Robbins J Circ Res; 1999 Oct; 85(9):841-7. PubMed ID: 10532952 [TBL] [Abstract][Full Text] [Related]
2. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. Yang Q; Sanbe A; Osinska H; Hewett TE; Klevitsky R; Robbins J J Clin Invest; 1998 Oct; 102(7):1292-300. PubMed ID: 9769321 [TBL] [Abstract][Full Text] [Related]
3. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Freiburg A; Gautel M Eur J Biochem; 1996 Jan; 235(1-2):317-23. PubMed ID: 8631348 [TBL] [Abstract][Full Text] [Related]
4. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. Gruen M; Gautel M J Mol Biol; 1999 Feb; 286(3):933-49. PubMed ID: 10024460 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains. Yang Q; Osinska H; Klevitsky R; Robbins J J Mol Cell Cardiol; 2001 Sep; 33(9):1649-58. PubMed ID: 11549344 [TBL] [Abstract][Full Text] [Related]
7. Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. Moolman-Smook JC; Mayosi B; Brink P; Corfield VA J Med Genet; 1998 Mar; 35(3):253-4. PubMed ID: 9541115 [TBL] [Abstract][Full Text] [Related]
8. Axial distribution of myosin binding protein-C is unaffected by mutations in human cardiac and skeletal muscle. Vydyanath A; Gurnett CA; Marston S; Luther PK J Muscle Res Cell Motil; 2012 May; 33(1):61-74. PubMed ID: 22415774 [TBL] [Abstract][Full Text] [Related]
9. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770 [TBL] [Abstract][Full Text] [Related]
10. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. Jacques AM; Copeland O; Messer AE; Gallon CE; King K; McKenna WJ; Tsang VT; Marston SB J Mol Cell Cardiol; 2008 Aug; 45(2):209-16. PubMed ID: 18573260 [TBL] [Abstract][Full Text] [Related]
11. Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. Kunst G; Kress KR; Gruen M; Uttenweiler D; Gautel M; Fink RH Circ Res; 2000 Jan 7-21; 86(1):51-8. PubMed ID: 10625305 [TBL] [Abstract][Full Text] [Related]
12. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664 [TBL] [Abstract][Full Text] [Related]
13. Comparison of two murine models of familial hypertrophic cardiomyopathy. McConnell BK; Fatkin D; Semsarian C; Jones KA; Georgakopoulos D; Maguire CT; Healey MJ; Mudd JO; Moskowitz IP; Conner DA; Giewat M; Wakimoto H; Berul CI; Schoen FJ; Kass DA; Seidman CE; Seidman JG Circ Res; 2001 Mar; 88(4):383-9. PubMed ID: 11230104 [TBL] [Abstract][Full Text] [Related]
14. Cardiac myosin binding protein C: its role in physiology and disease. Flashman E; Redwood C; Moolman-Smook J; Watkins H Circ Res; 2004 May; 94(10):1279-89. PubMed ID: 15166115 [TBL] [Abstract][Full Text] [Related]
15. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Watkins H; Conner D; Thierfelder L; Jarcho JA; MacRae C; McKenna WJ; Maron BJ; Seidman JG; Seidman CE Nat Genet; 1995 Dec; 11(4):434-7. PubMed ID: 7493025 [TBL] [Abstract][Full Text] [Related]
16. Cardiac Myosin-binding protein C and hypertrophic cardiomyopathy. Carrier L; Bonne G; Schwartz K Trends Cardiovasc Med; 1998 May; 8(4):151-7. PubMed ID: 21235926 [TBL] [Abstract][Full Text] [Related]
17. Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy. Helms AS; Tang VT; O'Leary TS; Friedline S; Wauchope M; Arora A; Wasserman AH; Smith ED; Lee LM; Wen XW; Shavit JA; Liu AP; Previs MJ; Day SM JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877118 [TBL] [Abstract][Full Text] [Related]
18. Structure, stability and dynamics of the central domain of cardiac myosin binding protein C (MyBP-C): implications for multidomain assembly and causes for cardiomyopathy. Idowu SM; Gautel M; Perkins SJ; Pfuhl M J Mol Biol; 2003 Jun; 329(4):745-61. PubMed ID: 12787675 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? Gautel M; Zuffardi O; Freiburg A; Labeit S EMBO J; 1995 May; 14(9):1952-60. PubMed ID: 7744002 [TBL] [Abstract][Full Text] [Related]
20. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. McConnell BK; Jones KA; Fatkin D; Arroyo LH; Lee RT; Aristizabal O; Turnbull DH; Georgakopoulos D; Kass D; Bond M; Niimura H; Schoen FJ; Conner D; Fischman DA; Seidman CE; Seidman JG J Clin Invest; 1999 Nov; 104(9):1235-44. PubMed ID: 10545522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]